Scientist Talks Benefits Of Psychedelics At Federal Health Agency Event

Scientist Talks Benefits Of Psychedelics At Federal Health Agency Event

A federal health agency hosted a leading psychedelics researcher on Tuesday for an event focused on the therapeutic potential of controlled substances such as psilocybin and DMT. Roland Griffiths, who has spent decades studying various entheogenic plants and fungi, described the existing scientific literature and future research objectives during a speech organized by the National Institute of Mental Health (NIMH). The event was part of NIMH’s “Innovation Speaker” series. The discussion, titled “Psilocybin: History, Neuropharmacology, and Implications for Therapeutics,” went over studies on the impact of psychedelics on mental health conditions such as depression and substance misuse, the subjective experience of individuals who’ve used such substances for recreational or spiritual purposes and the need for additional research into potential medical applications for psychedelics. For example, Griffiths presented a slide on the “phenomenological dimensions of mystical experience” elicited from psychedelics. People reported a greater sense of unity, sacredness, “universal love” and “transcendence of time and space,” among other feelings. Via NIMH. He also explained how research has shown that the medically supervised administration of moderate to high doses of psilocybin, the main psychoactive ingredient in so-called magic mushrooms, “can produce substantial and enduring decreases in depressive mood.” Via NIMH. When he…

Excerpt only …
READ MORE BELOW
Source : MJ moment
Link to original : Scientist Talks Benefits Of Psychedelics At Federal Health Agency Event
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.